Earl Miller Lecture: 'Focused MRI: Improving Value and Patient Care'

Scott Reeder MD, PhD, FISMRM, FSCBTMR, FAIMBME is a Professor, Vice Chair of Research and Chief of MRI in the Department of Radiology at the University of Wisconsin, Madison.  He joined UW-Madison in 2005 from Stanford University where he completed his radiology residency, and a fellowship in abdominal and cardiovascular imaging. Previously, he completed medical school at Johns Hopkins in Baltimore, where he also received his Masters and PhD in Biomedical Engineering. He is originally from Canada where he received his BScE in Engineering Physics at Queen's University in Kingston, Ontario.  In addition to his clinical and administrative duties, Dr. Reeder is also the Director of the UW Liver Imaging Research Group, an active NIH-funded group that performs research in technical development and translation of new imaging methods, particularly quantitative imaging biomarkers, to assess liver disease. Specific areas of research interests include development of new MRI methods for quantification of abdominal adiposity, liver fat, liver iron overload and other features of diffuse liver disease, quantification of perfusion in liver tumors, hemodynamics of portal hypertension and the use of new contrast agents in liver and biliary diseases. Dr.Reeder has authored over 250 manuscripts and is the inventor of 34 patents describing his clinical research and technical innovations.  Dr. Reeder is actively involved in many national and international societies, particularly the International Society for Magnetic Resonance in Medicine (ISMRM) and the Society of Computed Body Tomography and Magnetic Resonance (SCBT/MR), and he is a fellow of these societies, and currently the Vice President of the SCBT/MR. Dr. Reeder is also a Fellow of the American Institute of Medical and Biological Engineering (AIMBE).  More recently, Dr. Reeder founded Calimetrix, LLC, a company developing and manufacturing quantitative MRI phantoms, along with colleagues from UW-Madison.